
‘Threat to unborn life’: Senate majority tells FDA to backtrack on new generic abortion drug
Fifty-one senators making up a majority of the U.S. Senate have written to the U.S. Food and Drug Administration asking for officials to suspend approval of a generic abortion drug, like mifepristone, following the bureaucrats’ recent expansion of the use …